癌症：抗巨噬细胞治疗后的转移风险。 - Suppr

Cancer: Metastasis risk after anti-macrophage therapy.

作者信息

Keklikoglou Ioanna, De Palma Michele

机构信息

Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

出版信息

Nature. 2014 Nov 6;515(7525):46-7. doi: 10.1038/nature13931. Epub 2014 Oct 22.

DOI:10.1038/nature13931

PMID:25337881

Abstract

摘要

相似文献

Cancer: Metastasis risk after anti-macrophage therapy.

Nature. 2014 Nov 6;515(7525):46-7. doi: 10.1038/nature13931. Epub 2014 Oct 22.

Anti-CCL2: building a reservoir or opening the floodgates to metastasis?

Breast Cancer Res. 2015 May 21;17(1):68. doi: 10.1186/s13058-015-0573-4.

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.

Nature. 2014 Nov 6;515(7525):130-3. doi: 10.1038/nature13862. Epub 2014 Oct 22.

SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.

PLoS One. 2017 May 5;12(5):e0177089. doi: 10.1371/journal.pone.0177089. eCollection 2017.

Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.

Cancer Res. 2006 Jul 15;66(14):7176-84. doi: 10.1158/0008-5472.CAN-06-0825.

A study on local expression of NF-κB, CCL2 and their involvement in intratumoral macrophage infiltration in breast cancer.

Cell Mol Biol (Noisy-le-grand). 2016 Feb 29;62(2):116-25.

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Med Oncol. 2015 Nov;32(11):254. doi: 10.1007/s12032-015-0696-6. Epub 2015 Oct 20.

Breast cancer metastasis.

Cancer Genomics Proteomics. 2012 Sep-Oct;9(5):311-20.

Importance of chemokine (CC-motif) ligand 2 in breast cancer.

Int J Biol Markers. 2012 Oct 8;27(3):e179-85. doi: 10.5301/JBM.2012.9345.

Does breast cancer exist in a state of chaos?

Eur J Cancer. 1999 Jun;35(6):886-91. doi: 10.1016/s0959-8049(99)00067-2.

引用本文的文献

The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy.

Cancers (Basel). 2025 Jan 21;17(3):342. doi: 10.3390/cancers17030342.

Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues.

Front Immunol. 2024 Jul 15;15:1387651. doi: 10.3389/fimmu.2024.1387651. eCollection 2024.

Fatty acid metabolism of immune cells: a new target of tumour immunotherapy.

Cell Death Discov. 2024 Jan 20;10(1):39. doi: 10.1038/s41420-024-01807-9.

The role of host response to chemotherapy: resistance, metastasis and clinical implications.

Clin Exp Metastasis. 2024 Aug;41(4):495-507. doi: 10.1007/s10585-023-10243-5. Epub 2023 Nov 24.

Feed-forward loops between metastatic cancer cells and their microenvironment-the stage of escalation.

EMBO Mol Med. 2022 Jun 8;14(6):e14283. doi: 10.15252/emmm.202114283. Epub 2022 May 4.

ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.

Biomed Res Int. 2020 Oct 29;2020:2064582. doi: 10.1155/2020/2064582. eCollection 2020.

Tumor‑associated macrophages in lung cancer: Friend or foe? (Review).

Mol Med Rep. 2020 Nov;22(5):4107-4115. doi: 10.3892/mmr.2020.11518. Epub 2020 Sep 17.

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.

J Hematol Oncol. 2019 Jul 12;12(1):76. doi: 10.1186/s13045-019-0760-3.

Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses.

Cancer Immunol Immunother. 2019 Jul;68(7):1073-1085. doi: 10.1007/s00262-019-02338-4. Epub 2019 Jun 3.

Role of macrophages in peripheral nerve injury and repair.

Neural Regen Res. 2019 Aug;14(8):1335-1342. doi: 10.4103/1673-5374.253510.

本文引用的文献

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.

Nature. 2014 Nov 6;515(7525):130-3. doi: 10.1038/nature13862. Epub 2014 Oct 22.

Tumor-associated macrophages: from mechanisms to therapy.

Immunity. 2014 Jul 17;41(1):49-61. doi: 10.1016/j.immuni.2014.06.010.

The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.

Cancer Immunol Res. 2014 Aug;2(8):765-76. doi: 10.1158/2326-6066.CIR-13-0190. Epub 2014 Apr 29.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.

Macrophage biology in development, homeostasis and disease.

Nature. 2013 Apr 25;496(7446):445-55. doi: 10.1038/nature12034.

Macrophage regulation of tumor responses to anticancer therapies.

Cancer Cell. 2013 Mar 18;23(3):277-86. doi: 10.1016/j.ccr.2013.02.013.

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.

Invest New Drugs. 2013 Jun;31(3):760-8. doi: 10.1007/s10637-012-9869-8. Epub 2012 Aug 21.

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1.

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Nature. 2011 Jun 8;475(7355):222-5. doi: 10.1038/nature10138.

Macrophage regulation of tumor angiogenesis: implications for cancer therapy.

Mol Aspects Med. 2011 Apr;32(2):123-45. doi: 10.1016/j.mam.2011.04.005. Epub 2011 May 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cancer: Metastasis risk after anti-macrophage therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献